StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Northwest Biotherapeutics's pe ratio was 0.0× on Jan 31, 2023, against 76.8× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20230.0×−0.0
2022Dec 30, 20220.0×−76.8
2020Jul 31, 202076.8×–

More Northwest Biotherapeutics figures

See a number that looks wrong?